Stock Review: Apple (NASDAQ AAPL) Claims That Bendgate is Hyped

Apple Inc (NASDAQ AAPL) has responded swiftly to the firestorm of reports about the iPhone 6 Plus bending in owners’ pockets. Dubbed “Bendgate” by the media, the issue involves multiple reports and photos from iPhone 6 Plus owners who said their new phone bent while just riding around in their pockets all day. Apple Inc. stock has got hammered, falling more than 3% as investors … Continue reading Stock Review: Apple (NASDAQ AAPL) Claims That Bendgate is Hyped

Active Stock: Facebook (NASDAQ FB) Marks Out Details of Wifi Drones

Facebook Inc (NASDAQ FB) and Internet.org plans to use drones, to provide internet access to the people still not online, is not new. Facebook Connectivity Lab revealed its plans for the first time in March, and now more details have been provided by engineering director at Facebook Connectivity Lab, Yael Maguire at the 2014 Social Good Summit on Monday. It is estimated that only 15% … Continue reading Active Stock: Facebook (NASDAQ FB) Marks Out Details of Wifi Drones

Stock in News: Google (NASDAQ GOOG) Claims Samsung Already has iPhone 6 Like Products

As the “Internet of Things,” a societal revolution that will connect smart household appliances with cars, cell phones and a master home operating system, becomes more reality than fantasy, a fight to rule this world could emerge between two major players: Google Inc (NASDAQ GOOG) and Apple Inc (NASDAQ AAPL). In a recent interview on Bloomberg TV with Stephanie Ruhle and Erik Schatzker, Google Chairman … Continue reading Stock in News: Google (NASDAQ GOOG) Claims Samsung Already has iPhone 6 Like Products

Biotech Finance News

Biotech Stock Gilead Down Due To Weak Data Results

Shares of Gilead Sciences (GILD) declined approximately 0.9% to close the trading session on Sep 17 at $103.84 following a couple of setbacks — the failure of an oncology candidate to meet the primary endpoint in a phase II study and highly concerning data on the company’s blockbuster hepatitis C drug Sovaldi. Gilead’s pipeline candidate simtuzumab in combination with Eli Lilly and Company’s (LLY) Gemzar … Continue reading Biotech Stock Gilead Down Due To Weak Data Results

Biotech Stock

Active Stock in News: Bayer/Regeneron Successfully Expand Eylea Label

The HealthCare segment at Bayer (BAYRY) announced that its blockbuster eye treatment, Eylea, was approved for yet another indication in Japan. The drug was approved by the Ministry of Health, Labour and Welfare (MHLW) in Japan for the treatment of myopic choroidal neovascularization (myopic CNV). Eylea’s approval in the myopic CNV indication was based on encouraging results from the phase III MYRROR study. The drug … Continue reading Active Stock in News: Bayer/Regeneron Successfully Expand Eylea Label

Bitcoin News: Swedish Research Says Bitcoin Not Affecting Economy

Bitcoin has not affected the stability of Sweden’s economy, according to a new paper published by the country’s central bank. The latest issue of the Sveriges Riksbank Economic Review, published on 18th September, includes the article What is Bitcoin by Bjorn Segendorf, from the bank’s Financial Stability Department. Segendorf provides an overview of the bitcoin protocol, mining and price movements. He also includes a section … Continue reading Bitcoin News: Swedish Research Says Bitcoin Not Affecting Economy